Use of Liquid Concentrated Growth Factor in the Management of Necrotic Tissue After Facial Vascular Complications Induced by Hyaluronic Acid Injection
Use of Liquid Concentrated Growth Factor in the Management of Necrotic Tissue After Facial Vascular Complications Induced by Hyaluronic Acid Injection is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Use of Liquid Concentrated Growth Factor in the Management of Necrotic Tissue After Facial Vascular Complications Induced by Hyaluronic Acid Injection have?
Use of Liquid Concentrated Growth Factor in the Management of Necrotic Tissue After Facial Vascular Complications Induced by Hyaluronic Acid Injection has 5 citations in the OpenAlex counts ScholarIQ stores.
When was Use of Liquid Concentrated Growth Factor in the Management of Necrotic Tissue After Facial Vascular Complications Induced by Hyaluronic Acid Injection published?
Use of Liquid Concentrated Growth Factor in the Management of Necrotic Tissue After Facial Vascular Complications Induced by Hyaluronic Acid Injection has 2022 year in the ScholarIQ index.
What is the open-access status of Use of Liquid Concentrated Growth Factor in the Management of Necrotic Tissue After Facial Vascular Complications Induced by Hyaluronic Acid Injection?
Use of Liquid Concentrated Growth Factor in the Management of Necrotic Tissue After Facial Vascular Complications Induced by Hyaluronic Acid Injection has closed oa status in the ScholarIQ index.
What is the DOI of Use of Liquid Concentrated Growth Factor in the Management of Necrotic Tissue After Facial Vascular Complications Induced by Hyaluronic Acid Injection?
The DOI for Use of Liquid Concentrated Growth Factor in the Management of Necrotic Tissue After Facial Vascular Complications Induced by Hyaluronic Acid Injection is on the source record.
What is the PMID of Use of Liquid Concentrated Growth Factor in the Management of Necrotic Tissue After Facial Vascular Complications Induced by Hyaluronic Acid Injection?
The PMID for Use of Liquid Concentrated Growth Factor in the Management of Necrotic Tissue After Facial Vascular Complications Induced by Hyaluronic Acid Injection is on the source record.
What is the OpenAlex record for Use of Liquid Concentrated Growth Factor in the Management of Necrotic Tissue After Facial Vascular Complications Induced by Hyaluronic Acid Injection?
The OpenAlex for Use of Liquid Concentrated Growth Factor in the Management of Necrotic Tissue After Facial Vascular Complications Induced by Hyaluronic Acid Injection is on the source record.